Touch Bionics wins prestigious Queen’s Award for innovation
Company recognized for its achievements in the development and commercial success of the i-LIMB Hand
During an intensive application process for the award, Touch Bionics was scrutinized on both its innovation and business performance. Applicant companies had to demonstrate substantial improvement in business performance and commercial success.
“It could be said that our outstanding business success over the past three years has been somewhat outshone by the incredible reception given to our technology and patient stories, and so it is particularly gratifying to have secured a Queen’s Award for Enterprise, which looks beyond pure technical prowess to examine the commercial aspects of a business,” said
Since the launch of the i-LIMB Hand, more than 1,200 patients worldwide have been fitted with the first powered prosthetic hand to incorporate multi-articulating fingers. The i-LIMB Hand is the world’s first microprocessor controlled, myoelectric hand with five articulating digits, including a rotatable thumb, to offer users a range of grip patterns previously unavailable to them. With a range of cosmesis options and available in a variety of different sizes, including low profile feminine, the i-LIMB Hand is designed to meet the varied needs of its users.
The company’s innovation has not abated, and the company launched its ProDigits technology in
Commercially, Touch Bionics has also realized significant success through the 2008 acquisition of US company LIVINGSKIN, a provider of incredibly lifelike, aesthetic prosthetic products. The acquisition not only brought Touch Bionics a valuable complementary product line, but also a physical presence in
Product images are available for download at: http://www.touchbionics.com/press/picture-gallery-product
About Touch Bionics
Touch Bionics is a leading developer of advanced upper-limb prosthetics. In late 2009, Touch Bionics brought to market ProDigits, the world’s first bionic fingers for partial hand amputees. This revolutionary product followed the 2007 launch of the i-LIMB Hand, a first-to-market prosthetic device with five individually powered digits. The acquisition of LIVINGSKIN in 2008 enabled the company to apply its commercial and technical expertise into new cosmesis solutions for multi-articulating hands and digits. Touch Bionics continues to develop leading-edge technologies for the treatment of patients with upper-limb deficiencies. For more information, visit www.touchbionics.com.
SOURCE Touch Bionics